Macrophage Activation Therapy (GCMAF): Awakening the Body's Dormant Immune Scavengers

If the immune system is compared to an army, then macrophages are the front-line "scavengers" and "signal corps." The core of macrophage activation therapy (commonly known as GCMAF therapy) is to re-awaken these cells that have become "lazy" or "anesthetized" in the cancer environment.

The Dual Tasks of Macrophages

1. Direct Engulfment (Phagocytosis): Macrophages can actively recognize cancer cells and "eat" them.
2. Information Relay: After engulfment, macrophages communicate the characteristics of cancer cells to T cells and NK cells, launching a systemic joint attack.

Why Do Cancer Patients Need "Activation"?

Cancer cells secrete an enzyme called Nagalase, which blocks the natural pathway for producing "macrophage activating factors" in the body. This results in the presence of macrophages in the patient's body that remain blind to tumors.

GCMAF therapy bypasses the interference of cancer cells by producing or supplementing activation factors in vitro, directly igniting the fighting spirit of macrophages.

Characteristics of the Therapy

• Natural Source: Typically utilizes autologous blood or highly purified biological factors for induction.
• Mild Side Effects: Common reactions are only mild flu-like fevers, which usually indicate that the immune system is starting to work again.
• Diverse Combinations: Japanese physicians often combine macrophage therapy with Photodynamic Therapy (PDT) or Ozone Therapy, using tumor fragments to further strengthen the recognition capabilities of macrophages.

[Medical Supporter Compliance Statement] Macrophage therapy falls under the category of advanced regenerative medicine in Japan. We collaborate with multiple clinics equipped with professional CPC laboratories to ensure that every drop of activating factor is produced under strict control, safeguarding your health.

Compliance Notice: Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).